Integra Lifesciences Holdings (IART) Operating Margin (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Operating Margin data on file, last reported at 2.93% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin rose 698.0% year-over-year to 2.93%; the trailing twelve-month figure through Mar 2026 stood at 28.36% (down 2891.0% YoY), and the FY2025 full-year result was 30.17%, down 3194.0% from the prior year.
• Operating Margin declined to 2.93% in Q1 2026, from 5.3% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 17.04% in Q4 2022 to a low of 123.36% in Q2 2025.
• A 5-year average of 1.17% and a median of 5.3% in 2025 frame the typical range for Operating Margin.
• Across the five-year window, Operating Margin slumped 12263 bps in 2025 and surged 698 bps in 2026, its largest moves.
• Tracing IART's Operating Margin over 5 years: stood at 17.04% in 2022, then sank by 47 bps to 9.08% in 2023, then dropped by 11 bps to 8.05% in 2024, then tumbled by 34 bps to 5.3% in 2025, then tumbled by 45 bps to 2.93% in 2026.
• Business Quant data shows IART's Operating Margin at 2.93% in Q1 2026, 5.3% in Q4 2025, and 2.93% in Q3 2025.